Skip to main content

XR Securities LLC

Broker-Dealer
Location
CHICAGO, IL
Portfolio Value
Micro $5,350,673
Diversification
Moderately concentrated
Filing Date
Global Rank
#7,803 / 8,036 ▼ 4822
Top Industry
Drug Manufacturers - General 43.5%
3Y Alpha vs SPY
-4.2%
Period ended 1 year ago
Filed Jan 17, 2025 · 1y
20 quarters · since Mar 2020

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+58.9%
SPY
+76.5%
Annualised alpha
-4.2%
Max drawdown
−9.9%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

9 positions · as of Dec 31, 2024 · Δ vs Sep 30, 2024
Top Position
41.8%
+29.3 pts
Top 5
80.4%
+31.3 pts
Top 10
100.0%
+34.7 pts
HHI
2,251
Mar 2022 → Dec 2024 · range 609 – 6,352
Moderately concentrated+1,642

Portfolio Trend

20 quarters · across all stocks

Sector Breakdown

As of Dec 31, 2024
Sector % Portfolio Value
Healthcare 41.8% $2,238,800
Consumer Cyclical 16.8% $900,514
Industrials 13.8% $737,927
Communication Services 12.5% $671,070
Financial Services 6.7% $356,148
Technology 4.5% $241,722
Unclassified 3.8% $204,492

Last Quarter's Activity

Export CSV
Dec 31, 2024 vs Sep 30, 2024

Added To

Positions the filer increased
No qualifying positions this quarter.

Trimmed

Positions the filer reduced
9 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
No qualifying positions this quarter.

Sold Out

Positions the filer fully exited
25 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
9 positions · $5,350,673 total · as of Dec 31, 2024
Ticker Company Shares Value (USD) % of Portfolio History